Home LiteratureArticle Details
PMID: 8193530 Published · ppublish English Journal Article Review

Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death.

Current opinion in genetics & development ·Vol. 4 ·No. 1 ·1994-02-00 ·Pages 102-8

Amati B, Land H

Abstract

The Myc oncoprotein dimerizes with its partner, Max, to bind DNA, activate transcription, and promote cell proliferation, as well as programmed cell death. Max also forms homodimers or heterodimers with its alternative partners, Mad and Mxi-1. These complexes behave as antagonists of Myc/Max through competition for common DNA targets, and perhaps permit cellular differentiation.

MeSH Terms
Animals Apoptosis/physiology Base Sequence Basic Helix-Loop-Helix Leucine Zipper Transcription Factors Basic-Leucine Zipper Transcription Factors Binding Sites Cell Cycle/physiology Cell Differentiation/physiology DNA/genetics,metabolism DNA-Binding Proteins/physiology Helix-Loop-Helix Motifs/physiology Humans Leucine Zippers/physiology Proto-Oncogene Proteins c-myc/physiology Repressor Proteins Transcription Factors/physiology
Chemicals
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors Basic-Leucine Zipper Transcription Factors DNA-Binding Proteins MAX protein, human MXD1 protein, human Myc associated factor X Proto-Oncogene Proteins c-myc Repressor Proteins Transcription Factors DNA
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Amati B
Imperial Cancer Research Fund, London, UK.
Land H
Article Info
Journal
Current opinion in genetics & development
Abbr.
Curr Opin Genet Dev
ISSN
0959-437X
Published
1994-02-00
Pages
102-8
Language
English
Region
England
NLM ID
9111375
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com